1 Min Read
* OZEMPIC® APPROVED IN CANADA FOR THE TREATMENT OF ADULTS WITH TYPE 2 DIABETES
* SAYS OZEMPIC DEMONSTRATED CLINICALLY MEANINGFUL IMPROVEMENTS IN BLOOD SUGAR AND BODY WEIGHT VERSUS COMPARATORS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.